<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Subst Use Addict Treat</journal-id><journal-id journal-id-type="iso-abbrev">J Subst Use Addict Treat</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Journal of substance use and addiction treatment</journal-title></journal-title-group><issn pub-type="ppub">2949-8767</issn><issn pub-type="epub">2949-8759</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11090739</article-id><article-id pub-id-type="pmcid-ver">PMC11090739.319</article-id><article-id pub-id-type="pmcaid">11090739</article-id><article-id pub-id-type="pmcaiid">11090739</article-id><article-id pub-id-type="manuscript-id">NIHMS1972447</article-id><article-id pub-id-type="pmid">38369244</article-id><article-id pub-id-type="doi">10.1016/j.josat.2024.209314</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1972447</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1972447</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Association of Copayments with Healthcare Utilization and Expenditures among Medicaid Enrollees with a Substance Use Disorder</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Lazic</surname><given-names initials="A">Antonije</given-names></name><degrees>MHA</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tilford</surname><given-names initials="JM">J. Mick</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Davis</surname><given-names initials="VP">Victor P.</given-names></name><degrees>MS</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brown</surname><given-names initials="CC">Clare C.</given-names></name><degrees>PhD MPH</degrees><xref rid="A1" ref-type="aff">1</xref></contrib></contrib-group><aff id="A1"><label>1,</label>Fay W. Boozman College of Public Health, Department of Health Policy and Management, University of Arkansas for Medical Science, Little Rock, AR 72205, USA</aff><aff id="A2"><label>2</label>Actuarial Services &amp; Enterprise Underwriting, Arkansas Blue Cross Blue Shield, Little Rock, AR 72201, USA</aff><author-notes><corresp id="CR1">Corresponding author Clare C. Brown, PhD MPH- <email>ccbrown@uams.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>6</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>17</day><month>2</month><year>2024</year></pub-date><volume>161</volume><issue-id pub-id-type="pmc-issue-id">462293</issue-id><fpage>209314</fpage><lpage>209314</lpage><pub-history><event event-type="nihms-submitted"><date><day>08</day><month>03</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>01</day><month>06</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>01</day><month>06</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-06-01 00:25:39.977"><day>01</day><month>06</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1972447.pdf"/><abstract id="ABS1"><p id="P200">The purpose of this study was to examine the association between copayments and healthcare utilization and expenditures among enrollees with substance use disorders. This study used claims data (2020&#8211;2021) from a private insurer participating in Arkansas&#8217;s Medicaid expansion. We compared service utilization and expenditures for enrollees in different Medicaid program structures with varying copayments. Enrollees with incomes above 100% FPL (N=10,240) had copayments for substance use treatment services while enrollees below 100% FPL (N=2,478) did not. Demographic, diagnostic, utilization, and cost information came from claims and enrollment information. Substance use and clinical comorbidities were identified using claims from July through December 2020, and utilization and costs were evaluated in 2021. Generalized linear models (GLM) were used to estimate outcomes using single equation and two-part modeling. A gamma distribution and log link were used to model expenditures, and negative binomial models were used to model utilization. A falsification test comparing behavioral health telemedicine utilization, which had no cost sharing in either group, was used to assess whether differences in the groups may be responsible for observed findings. Substance use enrollees with copayments were less likely to have a substance use or behavioral health outpatient (&#8722;0.04 PP adjusted; p=0.001) or inpatient visit (&#8722;0.04 PP; p=0.001) relative to their counterparts without copayments, equal to a 17% reduction in substance use or behavioral health outpatient services and a nearly 50% reduction in inpatient visits. The reduced utilization among enrollees with a copayment was associated with a significant reduction in total expenses ($954; p=0.001) and expenses related to substance use or behavioral health services ($532; p=0.001). For enrollees with at least one behavioral health visit, there were no differences in outpatient or inpatient utilization or expenditures between enrollees with and without copayments. Copayments had no association with non-behavioral health or telemedicine services where neither group had cost sharing. Copayments serve as an initial barrier to substance use treatment, but are not associated with the amount of healthcare utilization conditional on using services. Policy makers and insurers should consider the role of copayments for treatment services among enrollees with substance use disorders in Medicaid programs.</p></abstract><kwd-group><kwd>Substance Use Disorders</kwd><kwd>Cost-Sharing</kwd><kwd>Copayments</kwd><kwd>Two-part modeling</kwd><kwd>Generalized Linear Modeling</kwd><kwd>Healthcare Access</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>